Safety, Tolerability, Pharmacokinetics of ELX-02 in Healthy Adult Volunteers
Clinical trial NCT02807961 · TERMINATED
Trial details
- NCT number
- NCT02807961
- Sponsor
- Eloxx Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-01
- Primary completion
- 2017-02-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.